Pappas Capital
Strategic Collaboration
Chiesi Ventures
On September 2, 2014 Chiesi announced the launch of its venture fund, Chiesi Ventures.
Our goal is to complement the current strategic interest of Chiesi Farmaceutici in the space of rare diseases by investing in early stage opportunities and accelerate the expansion of the Chiesi network in the US among universities, venture capital investors, rare disease patient organizations and start-ups developing treatments for rare diseases.
Strategic Collaboration
On September 2, 2014, Chiesi Ventures and Pappas Capital announced a strategic collaboration.
With the deal, Chiesi Ventures is able to leverage Pappas Capital’s expertise and network to access and assess deals and opportunities, lead investments and manage transactions.